RNA antagonist compounds for the modulation of beta-catenin

Details for Australian Patent Application No. 2008244211 (hide)

Owner Enzon Pharmaceuticals, Inc.

Inventors Worm, Jesper

Agent Griffith Hack

Pub. Number AU-A-2008244211

PCT Pub. Number WO2008/132234

Priority 60/915,371 01.05.07 US; 61/023,244 24.01.08 US

Filing date 30 April 2008

Wipo publication date 6 November 2008

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/132234 Priority application(s): WO2008/132234

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008244225-Receptacle, and method for the detection of fluorescence

2008244195-Production of hybrid Lactuca sativa seeds